{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:49:00Z","timestamp":1790142540283,"version":"4.0.1"},"reference-count":296,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG-4001-A1"],"award-info":[{"award-number":["RG-4001-A1"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Foundation","doi-asserted-by":"publisher","award":["RG 2010\/R\/31"],"award-info":[{"award-number":["RG 2010\/R\/31"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Health","award":["GR08\/7"],"award-info":[{"award-number":["GR08\/7"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["RG 260511-SEM_SEM"],"award-info":[{"award-number":["RG 260511-SEM_SEM"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community (EC) 7th Framework Program","award":["RG 280772-iONE"],"award-info":[{"award-number":["RG 280772-iONE"]}]},{"DOI":"10.13039\/501100004282","name":"The Evelyn Trust","doi-asserted-by":"crossref","award":["RG 69865"],"award-info":[{"award-number":["RG 69865"]}],"id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Bascule Charitable Trust","award":["RG 75149"],"award-info":[{"award-number":["RG 75149"]}]},{"name":"The Great Britain Sakakawa Foundation and a core support grant from the Wellcome Trust and MRC to the Wellcome Trust \u2013 Medical Research Council Cambridge Stem Cell Institute."},{"name":"NIH-OxCam"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.pneurobio.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T16:05:15Z","timestamp":1428249915000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis"],"prefix":"10.1016","volume":"127-128","author":[{"given":"Giulia","family":"Mallucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Peruzzotti-Jametti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bernstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pluchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2015.02.003_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/62.1.25","article-title":"Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases","volume":"62","author":"Aboul-Enein","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0022-510X(89)90144-5","article-title":"Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis","volume":"92","author":"Adams","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/glia.1106","article-title":"Immune function of microglia","volume":"36","author":"Aloisi","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","article-title":"Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?","volume":"123","author":"Antel","year":"2012","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/WNL.43.4.641","article-title":"Interferon beta in multiple sclerosis","volume":"43","author":"Arnason","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0065","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1126\/science.1103709","article-title":"bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS","volume":"306","author":"Arnett","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: The role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-012-0162-5","article-title":"Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned","volume":"10","author":"Atkins","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0090","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1279","article-title":"Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation","volume":"11","author":"Back","year":"2005","journal-title":"Nat. Med."},{"issue":"Pt 11","key":"10.1016\/j.pneurobio.2015.02.003_bib0095","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13311-012-0160-7","article-title":"Treatment of acute relapses in multiple sclerosis","volume":"10","author":"Berkovich","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y","article-title":"Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology","volume":"29","author":"Bitsch","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"Bjartmar","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/1352458503ms917oa","article-title":"Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration","volume":"9","author":"Bo","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"Bo","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archneur.64.1.76","article-title":"Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis","volume":"64","author":"Bo","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0150","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/awq250","article-title":"Demyelination versus remyelination in progressive multiple sclerosis","volume":"133","author":"Bramow","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.002","article-title":"Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis","volume":"238","author":"Brennan","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jnen\/64.2.147","article-title":"The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions","volume":"64","author":"Brink","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jnnp.25.4.315","article-title":"The distribution of plaques in the cerebrum in multiple sclerosis","volume":"25","author":"Brownell","year":"1962","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0171-2985(96)80024-6","article-title":"Macrophages in multiple sclerosis","volume":"195","author":"Bruck","year":"1996","journal-title":"Immunobiology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0195","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/1352458509106510","article-title":"Magnetic resonance evidence of cortical onset of multiple sclerosis","volume":"15","author":"Calabrese","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0185","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archneur.64.10.1416","article-title":"Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis","volume":"64","author":"Calabrese","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0180","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","article-title":"Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis","volume":"66","author":"Calabrese","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2011-300414","article-title":"Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study","volume":"83","author":"Calabrese","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0205","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/brain\/aws246","article-title":"Cortical lesion load associates with progression of disability in multiple sclerosis","volume":"135","author":"Calabrese","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/pri.22580","article-title":"Grey matter lesions in MS: from histology to clinical implications","volume":"7","author":"Calabrese","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0210","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0215","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.0b013e31828cf891","article-title":"Mitoxantrone-related acute leukemia in MS: an open or closed book?","volume":"80","author":"Chan","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","article-title":"Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis","volume":"346","author":"Chang","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0220","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/brain\/awn157","article-title":"Neurogenesis in the chronic lesions of multiple sclerosis","volume":"131","author":"Chang","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0225","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.23693","article-title":"Cortical remyelination: a new target for repair therapies in multiple sclerosis","volume":"72","author":"Chang","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0235","first-page":"554","article-title":"Histologie de la scl\u00e9rose en plaques","volume":"41","author":"Charcot","year":"1848","journal-title":"Gaz. Hop. Civ. Mil."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0240","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10072-011-0859-y","article-title":"Long-term efficacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China","volume":"33","author":"Chen","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0245","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0250","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s13311-011-0066-9","article-title":"Cell-based therapy for neural disorders \u2013 anticipating challenges","volume":"8","author":"Chiu","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0255","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0260","first-page":"CD006264","article-title":"Corticosteroids for the long-term treatment in multiple sclerosis","author":"Ciccone","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0265","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc0800484","article-title":"Anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clim.2011.02.011","article-title":"Immune mechanisms of new therapeutic strategies in MS: teriflunomide","volume":"142","author":"Claussen","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0275","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.1158-11.2011","article-title":"FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions","volume":"31","author":"Clemente","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0280","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0285","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0290","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0295","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0303","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/103.2.281","article-title":"Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients","volume":"103","author":"Confavreux","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(13)70308-9","article-title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Confavreux","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0310","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0315","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of Vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1750-3639.1996.tb00852.x","article-title":"Biochemistry of demyelination","volume":"6","author":"Cuzner","year":"1996","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0325","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/brain\/124.8.1635","article-title":"Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions","volume":"124","author":"De Groot","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.med.58.071105.111552","article-title":"New therapeutic approaches for multiple sclerosis","volume":"58","author":"De Jager","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0340","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2015.02.003_bib0345","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.0b013e3181c97d99","article-title":"Interferon-beta mechanisms of action in multiple sclerosis","volume":"74","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0350","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2003.11.010","article-title":"Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis","volume":"148","author":"Diab","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0365","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0360","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/brain\/awm206","article-title":"Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients","volume":"130","author":"Dutta","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0355","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.22337","article-title":"Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients","volume":"69","author":"Dutta","year":"2011","journal-title":"Ann. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2015.02.003_bib0375","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1177\/135245850401000103","article-title":"Natural history of primary progressive multiple sclerosis","volume":"10","author":"Ebers","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0380","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/aws105","article-title":"Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis","volume":"135","author":"Elliott","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0385","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0390","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"Ermis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0395","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1352458508096875","article-title":"Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation","volume":"15","author":"Fagius","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0400","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.53.3.448","article-title":"The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis","volume":"53","author":"Fazekas","year":"1999","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.pneurobio.2015.02.003_bib0405","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0410","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/1352458512443995","article-title":"The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately \u2013 no","volume":"18","author":"Filippi","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1474-4422(12)70003-0","article-title":"Association between pathological and MRI findings in multiple sclerosis","volume":"11","author":"Filippi","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0420","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005568","article-title":"Cell-based therapeutics: the next pillar of medicine","volume":"5","author":"Fischbach","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0425","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0430","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","article-title":"Disease-specific molecular events in cortical multiple sclerosis lesions","volume":"136","author":"Fischer","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0435","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcb.22775","article-title":"Teratomas from pluripotent stem cells: a clinical hurdle","volume":"111","author":"Fong","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0440","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0445","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1177\/1352458512458169","article-title":"Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS","volume":"18","author":"Fox","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0450","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","article-title":"Why does remyelination fail in multiple sclerosis?","volume":"3","author":"Franklin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0455","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/glia.22622","article-title":"The translational biology of remyelination: past, present, and future","volume":"62","author":"Franklin","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0460","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3","article-title":"Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system","volume":"50","author":"Franklin","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0465","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awm246","article-title":"T cells and microglia as drivers of multiple sclerosis pathology","volume":"130","author":"Friese","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0470","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0475","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.2414848","article-title":"Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity","volume":"230","author":"Fujinami","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cbpa.2014.01.008","article-title":"The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders","volume":"18","author":"Galban-Horcajo","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0485","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0490","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/1352458512443997","article-title":"The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately \u2013 yes","volume":"18","author":"Geurts","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0505","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awg179","article-title":"Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis","volume":"126","author":"Geurts","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0495","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/nen.0b013e3181461f54","article-title":"Extensive hippocampal demyelination in multiple sclerosis","volume":"66","author":"Geurts","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0500","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.01.018","article-title":"Gray matter pathology in (chronic) MS: modern views on an early observation","volume":"282","author":"Geurts","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0510","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0515","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1212\/01.wnl.0000258545.73854.cf","article-title":"Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"68","author":"Goodin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0520","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0525","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0530","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5966\/sctm.2012-0015","article-title":"Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis","volume":"1","author":"Harris","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0535","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","article-title":"Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial","volume":"360","author":"Hartung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0540","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0545","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0550","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0555","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/WNL.0b013e3181b59c40","article-title":"Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis","volume":"73","author":"Hedstrom","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0560","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1352458511399610","article-title":"Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis","volume":"17","author":"Hedstrom","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0565","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0570","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/aje\/154.1.69","article-title":"Cigarette smoking and incidence of multiple sclerosis","volume":"154","author":"Hernan","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0575","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.170.2.607","article-title":"Tumor necrosis factor identified in multiple sclerosis brain","volume":"170","author":"Hofman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0580","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0585","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-59544-7.00011-1","article-title":"Current status of myelin replacement therapies in multiple sclerosis","volume":"201","author":"Huang","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0590","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/ern.11.34","article-title":"Retinoid X receptors as a potential avenue for regenerative medicine in multiple sclerosis","volume":"11","author":"Huang","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0595","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","article-title":"Interferon, beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group","volume":"45","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0600","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"International Multiple Sclerosis Genetics","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0605","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"Investigators","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0610","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/brain\/awn080","article-title":"Remyelination protects axons from demyelination-associated axon degeneration","volume":"131","author":"Irvine","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0615","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.410110414","article-title":"Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions","volume":"11","author":"Itoyama","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0620","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0625","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0630","first-page":"157","volume":"vol. 1","author":"JM","year":"1877"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0645","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0635","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.4049\/jimmunol.174.11.6854","article-title":"Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome","volume":"174","author":"Johnson","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0640","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0074-7742(07)79004-9","article-title":"The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?","volume":"79","author":"Johnson","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0650","first-page":"2052","article-title":"IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)","volume":"119","author":"Jones","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0655","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1191\/1352458502ms849xx","article-title":"The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study","volume":"8","author":"Kalkers","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0660","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0665","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0670","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0675","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.23938","article-title":"Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis","volume":"73","author":"Khan","year":"2013","journal-title":"Ann. Neurol."},{"issue":"Pt 1","key":"10.1016\/j.pneurobio.2015.02.003_bib0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/brain\/122.1.17","article-title":"Cortical lesions in multiple sclerosis","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0685","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11591110-000000000-00000","article-title":"The mechanism of action of interferon-beta in relapsing multiple sclerosis","volume":"25","author":"Kieseier","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0690","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/glia.21182","article-title":"Differential and cooperative actions of Olig1 and Olig2 transcription factors on immature proliferating cells after contusive spinal cord injury","volume":"59","author":"Kim","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0695","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1352458507082604","article-title":"Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome","volume":"14","author":"Kimiskidis","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0700","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneurol.2010.197","article-title":"Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis","volume":"67","author":"Klawiter","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0705","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/brain\/aws242","article-title":"A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology","volume":"135","author":"Kolasinski","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0710","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1750-3639.1999.tb00547.x","article-title":"Axonal pathology in multiple sclerosis. A historical note","volume":"9","author":"Kornek","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0715","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0720","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0730","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0725","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1750-3639.2006.00041.x","article-title":"Widespread demyelination in the cerebellar cortex in multiple sclerosis","volume":"17","author":"Kutzelnigg","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0735","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/01.WNL.0000127615.15768.AE","article-title":"Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects","volume":"62","author":"Lampasona","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0740","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0745","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0750","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-510X(02)00421-5","article-title":"Hypoxia-like tissue injury as a component of multiple sclerosis lesions","volume":"206","author":"Lassmann","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0755","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2990.2011.01189.x","article-title":"Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis","volume":"37","author":"Lassmann","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0760","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1093\/brain\/aws260","article-title":"Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration","volume":"135","author":"Lassmann","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0765","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.expneurol.2013.12.003","article-title":"Multiple sclerosis: Lessons from molecular neuropathology","volume":"262","author":"Lassmann","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0770","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0775","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/WNL.60.1.44","article-title":"Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial","volume":"60","author":"Leary","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0780","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0785","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0790","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0074-7742(07)79006-2","article-title":"Molecular mimicry in multiple sclerosis","volume":"79","author":"Libbey","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0795","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0800","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0805","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00429-013-0665-9","article-title":"Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS","volume":"220","author":"Longoni","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0810","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey, National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0815","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"Pt 12","key":"10.1016\/j.pneurobio.2015.02.003_bib0820","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/122.12.2279","article-title":"A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases","volume":"122","author":"Lucchinetti","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0825","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0830","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0835","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.410090316","article-title":"Evidence for a \u201cdying-back\u201d gliopathy in demyelinating disease","volume":"9","author":"Ludwin","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0840","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(84)90037-6","article-title":"Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths","volume":"64","author":"Ludwin","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0845","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1474-4422(08)70110-8","article-title":"Getting specific: monoclonal antibodies in multiple sclerosis","volume":"7","author":"Lutterotti","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0850","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","article-title":"Spinal-cord MRI in multiple sclerosis","volume":"2","author":"Lycklama","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0855","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0865","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnen\/63.3.262","article-title":"Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions","volume":"63","author":"Mahad","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0860","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0870","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/1352458505ms1181cr","article-title":"Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis","volume":"11","author":"Mancardi","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0875","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/WCO.0b013e32833960f6","article-title":"New drug therapies for multiple sclerosis","volume":"23","author":"Mangas","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0880","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.0b013e3181dc1ae0","article-title":"Evidence Report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"74","author":"Marriott","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0885","first-page":"CD002127","article-title":"Mitoxantrone for multiple sclerosis","author":"Martinelli Boneschi","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0890","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1212\/WNL.0b013e318238ee00","article-title":"Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone","volume":"77","author":"Martinelli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0895","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1352458513494959","article-title":"Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes","volume":"20","author":"Martinelli","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0900","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1474-4422(04)00771-9","article-title":"How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders","volume":"3","author":"Martino","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0905","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/brain\/awr115","article-title":"Therapeutic stem cell plasticity orchestrates tissue plasticity","volume":"134","author":"Martino","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0910","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000117451","article-title":"Cerebrospinal-fluid ciliary neurotrophic factor in neurological patients","volume":"37","author":"Massaro","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0915","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxic oligodendroglial death and demyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0920","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-065X.2012.01135.x","article-title":"The innate immune system in demyelinating disease","volume":"248","author":"Mayo","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0925","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-1-60761-720-4_19","article-title":"Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease","volume":"900","author":"McCarthy","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0930","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm1202","article-title":"Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis","volume":"11","author":"McMahon","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0935","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ana.24163","article-title":"Pathologic heterogeneity persists in early active multiple sclerosis lesions","volume":"75","author":"Metz","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0940","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40263-013-0068-8","article-title":"Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic","volume":"27","author":"Mi","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0945","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1474-4422(05)70095-8","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, Part 2: Non-conventional MRI, recovery processes, and management","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0950","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, Part I: Natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0955","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood\u2013brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0960","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jnc.12705","article-title":"Macrophages and CNS remyelination","volume":"130","author":"Miron","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0965","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab","year":"2007","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0970","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/glia.22547","article-title":"SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis","volume":"61","author":"Moll","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0975","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e3181cec45c","article-title":"MRI criteria for MS in patients with clinically isolated syndromes","volume":"74","author":"Montalban","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0985","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0980","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0990","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity?","volume":"9","author":"Munz","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0995","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s40265-013-0146-8","article-title":"Promoting remyelination in multiple sclerosis-recent advances","volume":"73","author":"Munzel","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1000","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nri954","article-title":"The lineage decisions of helper T cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2004.12.006","article-title":"PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination","volume":"19","author":"Murtie","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1015","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1523\/JNEUROSCI.0805-13.2013","article-title":"Ascl1\/Mash1 promotes brain oligodendrogenesis during myelination and remyelination","volume":"33","author":"Nakatani","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrn2797","article-title":"Myelination and the trophic support of long axons","volume":"11","author":"Nave","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.neuro.30.051606.094309","article-title":"Axon\u2013glial signaling and the glial support of axon function","volume":"31","author":"Nave","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/1531-8249(200009)48:3<362::AID-ANA11>3.0.CO;2-6","article-title":"Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination","volume":"48","author":"Niehaus","year":"2000","journal-title":"Ann. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.pneurobio.2015.02.003_bib1035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/brain\/121.4.687","article-title":"Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms","volume":"121","author":"Nijeholt","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2377-13-111","article-title":"Endogenous retroviruses and multiple sclerosis-new pieces to the puzzle","volume":"13","author":"Nissen","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","article-title":"Randomized trial of oral teriflunomide for relapsing multiple sclerosis","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1179\/016164106X98099","article-title":"The B cell response in multiple sclerosis","volume":"28","author":"Owens","year":"2006","journal-title":"Neurol. Res."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/1073858410386615","article-title":"Viruses and multiple sclerosis","volume":"17","author":"Owens","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1060","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1070","doi-asserted-by":"crossref","first-page":"164ps125","DOI":"10.1126\/scitranslmed.3005090","article-title":"Pluripotent stem cells: immune to the immune system?","volume":"4","author":"Pearl","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1075","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1080","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroscience.2014.04.036","article-title":"The role of the immune system in central nervous system plasticity after acute injury","volume":"26","author":"Peruzzotti-Jametti","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1100","first-page":"47","article-title":"Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis","volume":"48","author":"Petry","year":"2000","journal-title":"Pathol.-Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","article-title":"Placebo-controlled, multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/glia.22500","article-title":"How stem cells speak with host immune cells in inflammatory brain diseases","volume":"61","author":"Pluchino","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nature03889","article-title":"Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism","volume":"436","author":"Pluchino","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.21745","article-title":"Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates","volume":"66","author":"Pluchino","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0b013e3182635645","article-title":"Increased PK11195 PET binding in the cortex of patients with MS correlates with disability","volume":"79","author":"Politis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1135","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-12-11","article-title":"Meningeal and cortical grey matter pathology in multiple sclerosis","volume":"12","author":"Popescu","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1145","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0b013e31821a44f1","article-title":"A case of multiple sclerosis presenting with inflammatory cortical demyelination","volume":"76","author":"Popescu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1155","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00415-008-0954-z","article-title":"Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis","volume":"255","author":"Presslauer","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2015.02.003_bib1165","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1212\/WNL.0b013e3181c97e39","article-title":"The mechanism of action of glatiramer acetate treatment in multiple sclerosis","volume":"74","author":"Racke","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2010.02.012","article-title":"Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis","volume":"292","author":"Radue","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1180","doi-asserted-by":"crossref","first-page":"470949","DOI":"10.1155\/2012\/470949","article-title":"Ethical implications in the use of embryonic and adult neural stem cells","volume":"2012","author":"Ramos-Zuniga","year":"2012","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/1352458513508835","article-title":"A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS","volume":"20","author":"Ramo-Tello","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1184","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised, double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1185","doi-asserted-by":"crossref","first-page":"948976","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"Pt 11","key":"10.1016\/j.pneurobio.2015.02.003_bib1190","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/122.11.2047","article-title":"Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study","volume":"122","author":"Reindl","year":"1999","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2015.02.003_bib1195","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0022-510X(09)70012-7","article-title":"Concepts of induction and escalation therapy in multiple sclerosis","volume":"277","author":"Rieckmann","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-61779-373-8_28","article-title":"Combinatorial glycoarray","volume":"808","author":"Rinaldi","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(05)70171-X","article-title":"Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes","volume":"4","author":"Rocca","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1210","first-page":"53","article-title":"Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis","volume":"86","author":"Rodgers","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1215","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"Rosland","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.brainresrev.2007.03.001","article-title":"Janus faces of microglia in multiple sclerosis","volume":"54","author":"Sanders","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1230","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"Sargsyan","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp-2012-304333","article-title":"Onset of secondary progressive phase and long-term evolution of multiple sclerosis","volume":"85","author":"Scalfari","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1245","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ni1545","article-title":"Finding a way out: lymphocyte egress from lymphoid organs","volume":"8","author":"Schwab","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1250","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1054\/bjoc.2001.2020","article-title":"Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours","volume":"85","author":"Scotton","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1255","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI115102","article-title":"Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions","volume":"87","author":"Selmaj","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1260","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1265","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.exphem.2012.07.003","article-title":"Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis","volume":"40","author":"Shevchenko","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1270","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.153.5.933","article-title":"Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood\u2013brain barrier in experimental autoimmune encephalomyelitis","volume":"153","author":"Sixt","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458505ms1190oa","article-title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","volume":"11","author":"Sloka","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1280","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1750-3639.2007.00066.x","article-title":"Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy","volume":"17","author":"Smith","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/280395a0","article-title":"Central remyelination restores secure conduction","volume":"280","author":"Smith","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1290","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1523\/JNEUROSCI.1716-06.2006","article-title":"Identification of Sox17 as a transcription factor that regulates oligodendrocyte development","volume":"26","author":"Sohn","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1300","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/375739b0","article-title":"Multiple sclerosis. Presenting an odd autoantigen","volume":"375","author":"Steinman","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1305","doi-asserted-by":"crossref","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1310","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/aws313","article-title":"Fibronectin aggregation in multiple sclerosis lesions impairs remyelination","volume":"136","author":"Stoffels","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1315","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1468-1331.2008.02122.x","article-title":"Smoke exposure increases the risk for multiple sclerosis","volume":"15","author":"Sundstrom","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1320","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jocn.2007.08.017","article-title":"Spontaneous regression of syringomyelia \u2013 review of the current aetiological theories and implications for surgery","volume":"15","author":"Sung","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1325","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.24201","article-title":"Early netrin-1 expression impairs central nervous system remyelination","volume":"76","author":"Tepavcevic","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1335","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2012.03.003","article-title":"Direct conversion of fibroblasts into stably expandable neural stem cells","volume":"10","author":"Thier","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1340","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.4049\/jimmunol.173.8.5209","article-title":"Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis","volume":"173","author":"Toft-Hansen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1345","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1750-3639.2009.00343.x","article-title":"Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients","volume":"20","author":"Torkildsen","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1350","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P02.021","article-title":"Safety, tolerability and pharmacokinetics of the anti-LINGO-1 monoclonal antibody BIIB033 in healthy volunteers and subjects with multiple sclerosis","volume":"78","author":"Tran","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1355","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1365","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1371","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2014-307721","article-title":"Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy","volume":"86","author":"Tuohy","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1370","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/WCO.0b013e32832b4c76","article-title":"Preactive lesions in multiple sclerosis","volume":"22","author":"Van der Valk","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1375","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2010.01.006","article-title":"Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade","volume":"126","author":"Van der Walt","year":"2010","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/187152711794488566","article-title":"Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies","volume":"10","author":"van Noort","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1385","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJMc1215357","article-title":"PML in a patient treated with dimethyl fumarate from a compounding pharmacy","volume":"368","author":"van Oosten","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1390","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1352458512460604","article-title":"Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis","volume":"19","author":"Vennegoor","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1395","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1352458513507821","article-title":"Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial","volume":"20","author":"Vermersch","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1404","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2015.02.003_bib1400","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1212\/WNL.0b013e3181c97f5a","article-title":"Mitoxantrone and cytotoxic drugs\u2019 mechanisms of action","volume":"74","author":"Vollmer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1405","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jmri.20564","article-title":"Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration","volume":"23","author":"Vrenken","year":"2006","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1410","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/acn3.60","article-title":"A randomized controlled phase II trial of riluzole in early multiple sclerosis","volume":"1","author":"Waubant","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1415","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410330202","article-title":"Molecular dissection of the myelinated axon","volume":"33","author":"Waxman","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1425","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/01.wnl.0000237551.26858.39","article-title":"Neocortical neuronal, synaptic, and glial loss in multiple sclerosis","volume":"67","author":"Wegner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1430","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1242\/jeb.132.1.43","article-title":"Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells","volume":"132","author":"Wekerle","year":"1987","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1435","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1440","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31826aadaf","article-title":"Antibodies to MOG in NMO: a seasoned veteran finds a new role","volume":"79","author":"Willison","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1445","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","article-title":"Riluzole","volume":"348","author":"Wokke","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ana.21079","article-title":"Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial","volume":"61","author":"Wolinsky","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1455","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nm.1957","article-title":"Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain","volume":"15","author":"Wu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1460","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1465","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","article-title":"Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study","volume":"227","author":"Yamout","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pneurobio.2015.02.003_bib1470","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/glia.21052","article-title":"Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes","volume":"58","author":"Ziabreva","year":"2010","journal-title":"Glia"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:14:49Z","timestamp":1717827289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008215000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":296,"alternative-id":["S0301008215000192"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.02.003","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}